Interesting.
You will also find that Dr Walter & Dr Percy have been a part of and play a significant role in approvals. You will note that it is not by chance that the ASX announcement included their names to clearly state that they were backing this up.
Dr Percy
Since 1998, Dr. Percy has served as Director of the American Board of Psychiatry and Neurology. He is a Fellow in both the American Academy of Pediatrics and American Academy of Neurology and is actively involved in many national and international pediatric and neurology societies. Dr. Percy is also active in many areas of research including the UAB Mental Retardation Research Center (MRRC), where he serves as an MRRC Scientist.
Dr. Percy was recently named one of America's Best Doctors on the www.bestdoctors.com web site. Only 4% of America's doctors are recognized in these listings based on surveys sent to leading specialists around the world
Dr Kaufmann
Director of Rett Syndrome Program; Senior Associate in Neurology; Co-Director of Fragile X Syndrome Program; Co-Director of Down Syndrome Program; Clinical Co-Director, Translational Neuroscience CenterProfessor of Neurology, Harvard Medical School
An Interesting paper was published by them including Daniel Glaze and others regarding Rett. It was published in Journal of neurodevelopment on 22 July 2014.
I am beginning to believe that this study would have formed the base or at least a benchmark to make comparison with. Statistically significant improvements would have been observed and hence a succesful trial.
Moving forward with NNZ-2566 here is where NEU is headed
The primary focus is on the pathogenesis of neurodevelopmental disorders including autism, Fragile X Syndrome, tuberous sclerosis, Turner Syndrome, 22q Deletion Syndrome, Prader-Willi Angelman Syndrome, Williams Syndrome, Lysosomal Storage Diseases, dyslexia, specific language impairment and Fetal Alcohol Syndrome.
- Forums
- ASX - By Stock
- NEU
- A little caution...
A little caution..., page-12
-
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$15.05 |
Change
-0.540(3.46%) |
Mkt cap ! $1.918B |
Open | High | Low | Value | Volume |
$15.38 | $15.40 | $14.94 | $1.272M | 84.18K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 109 | $15.04 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.06 | 377 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 83 | 15.040 |
4 | 392 | 15.030 |
4 | 333 | 15.020 |
3 | 345 | 15.010 |
6 | 4043 | 15.000 |
Price($) | Vol. | No. |
---|---|---|
15.060 | 429 | 7 |
15.070 | 622 | 7 |
15.080 | 464 | 4 |
15.090 | 824 | 6 |
15.100 | 1486 | 5 |
Last trade - 10.57am 02/09/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
1CG
ONE CLICK GROUP LIMITED
Mark Waller, MD
Mark Waller
MD
Previous Video
Next Video
SPONSORED BY The Market Online